PMID- 34926522 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211221 IS - 2296-858X (Print) IS - 2296-858X (Electronic) IS - 2296-858X (Linking) VI - 8 DP - 2021 TI - Effect of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PG - 779019 LID - 10.3389/fmed.2021.779019 [doi] LID - 779019 AB - Background: This systematic review and meta-analysis aimed to evaluate the effect of neuromuscular electrical stimulation (NMES) on quadriceps muscle strength, pain, and function outcomes following total knee arthroplasty (TKA). Methods: PubMed/Medline, Embase, Web of Science, CENTRAL, Scopus, PsycINFO, PEDro, CINAHL, CNKI, and Wanfang were systematically searched for randomized controlled trials (RCTs) from their inception to 18 June 2021. Results: Nine RCTs that involving 691 patients were included in the meta-analysis. Our pooled analysis showed that NMES improved quadriceps muscle strength after TKA within 1 months [standardized mean difference (SMD): 0.81; 95% CI: 0.51-1.11], 1-2 months (SMD: 0.55; 95% CI: 0.13-0.97), 3-4 months (SMD: 0.42; 95% CI: 0.18-0.66), and 12-13 months (SMD: 0.46; 95% CI: 0.18-0.74), pain between 1 and 2 months [mean difference (MD): -0.62; 95% CI: -1.04 to -0.19], pain between 3 and 6 months (MD: -0.44; 95% CI: -0.74 to -0.14) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) between 3 and 4 months (MD: -0.43; 95% CI: -0.82 to -0.05), timed up and go test (TUG) within 1 month (MD: -2.23; 95% CI: -3.40 to -1.07), 3 minutes walk test between 3 and 6 months (MD: 28.35; 95% CI: 14.55-42.15), and SF-36 MCS between 3 and 6 months after TKA (MD: 4.20, 95% CI: 2.41-5.98). Conclusion: As a supplementary treatment after TKA, postoperative NMES could improve the short-term to long-term quadriceps muscle strength, mid-term pain, and mid-term function following TKA. However, many outcomes failed to achieve statistically meaningful changes and minimal clinically important difference (MCID), thus the clinical benefits remained to be confirmed. Level of Evidence: Therapeutic level I. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42021265609. CI - Copyright (c) 2021 Peng, Wang, Zeng, Wu, Si and Shen. FAU - Peng, Linbo AU - Peng L AD - Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China. FAU - Wang, Kexin AU - Wang K AD - Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, China. FAU - Zeng, Yi AU - Zeng Y AD - Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China. FAU - Wu, Yuangang AU - Wu Y AD - Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China. FAU - Si, Haibo AU - Si H AD - Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China. FAU - Shen, Bin AU - Shen B AD - Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China. LA - eng PT - Systematic Review DEP - 20211203 PL - Switzerland TA - Front Med (Lausanne) JT - Frontiers in medicine JID - 101648047 PMC - PMC8677678 OTO - NOTNLM OT - function OT - meta-analysis OT - neuromuscular electrical stimulation OT - pain OT - quadriceps muscle strength OT - systematic review OT - total knee arthroplasty COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/12/21 06:00 MHDA- 2021/12/21 06:01 PMCR- 2021/12/03 CRDT- 2021/12/20 06:18 PHST- 2021/09/17 00:00 [received] PHST- 2021/11/08 00:00 [accepted] PHST- 2021/12/20 06:18 [entrez] PHST- 2021/12/21 06:00 [pubmed] PHST- 2021/12/21 06:01 [medline] PHST- 2021/12/03 00:00 [pmc-release] AID - 10.3389/fmed.2021.779019 [doi] PST - epublish SO - Front Med (Lausanne). 2021 Dec 3;8:779019. doi: 10.3389/fmed.2021.779019. eCollection 2021.